Cerus Endovascular
Oxford
About Cerus Endovascular
Cerus Endovascular Ltd designs and develops interventional neuroradiology devices and delivery systems. The company develops e-clipse, an aneurysm occlusive device that addresses the current neurovascular aneurysm procedures attempted by surgical clipping, minimally invasive metal coils and liquid embolics. The company was founded in 2011 and is based in Oxford, United Kingdom.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.3M
- Funding stage: M&A
- Last round: Series B (Feb 2020)
- Website: cerusendo.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cerus-endovascular-2451927 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.